` IQAIF (IQ-AI Ltd) vs S&P 500 Comparison - Alpha Spread

IQAIF
vs
S&P 500

Over the past 12 months, IQAIF has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +12% growth.

Stocks Performance
IQAIF vs S&P 500

Loading
IQAIF
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
IQAIF vs S&P 500

Loading
IQAIF
S&P 500
Difference
www.alphaspread.com

Performance By Year
IQAIF vs S&P 500

Loading
IQAIF
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
IQ-AI Ltd vs Peers

S&P 500
IQAIF
VEEV
EIS
SMART
CIM
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

IQ-AI Ltd
Glance View

Market Cap
4.4m USD
Industry
Health Care

IQ-AI Ltd. is a holding company, which engages in the provision of clinical treatments to patients in the field of medical imaging diagnostics. The firm provides health care technology solutions to the artificial intelligence (AI) medical imaging market. Through its subsidiary, StoneChecker Software Ltd, It offers medical imaging software for urolithiasis that analyses and presents stone metrics, including stone size, volume, density, skin to stone distance, and stone architecture through TexRAD analysis within the healthcare information technology (IT) systems. Through its subsidiary, Imaging Biometrics, LLC, It specializes in the design and manufacture of visualization tools, the application of machine learning and AI software solutions, and the development and clinical testing of imaging endpoints and biomarkers. Its portfolio consists of IB Neuro and IB Diffusion that are used in treatment of brain tumors, strokes and pathologies.

IQAIF Intrinsic Value
0.04 USD
Undervaluation 45%
Intrinsic Value
Price
Back to Top